Question 1

Does Franklin Templeton own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Franklin Templeton holds 2,771,839 shares of REGN (Regeneron Pharmaceuticals), worth $1.7B.

Question 2

How many shares of REGN does Franklin Templeton own?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton holds 2,771,839 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is Franklin Templeton's REGN position worth?

Accepted Answer

As of its Q2 2026 13F, Franklin Templeton's REGN position is worth $1.7B.

Question 4

Is Franklin Templeton buying or selling REGN?

Accepted Answer

In Q2 2026, Franklin Templeton increased its REGN position by 49,768 shares (+1.8%).

Question 5

When did Franklin Templeton first buy REGN?

Accepted Answer

Franklin Templeton already held REGN in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.8M	+1.8%	$1.7B	0.4%	$622.81	39
2026-Q1	Increased	2.7M	+6.3%	$2.1B	0.5%	$770.59	48
2025-Q4	Increased	2.6M	+4.4%	$2B	0.5%	$768.90	40
2025-Q3	Increased	2.5M	+6.0%	$1.4B	0.3%	$559.40	41
2025-Q2	Increased	2.3M	+1.6%	$1.2B	0.3%	$521.53	39
2025-Q1	Increased	2.3M	+11.3%	$1.4B	0.4%	$629.11	42
2024-Q4	Increased	2M	+7.9%	$1.5B	0.4%	$705.67	41
2024-Q3	Decreased	1.9M	-1.4%	$1.9B	0.5%	$1,041.41	0